The HHS will require all new vaccines to undergo placebo-controlled trials, likely slowing down approvals and decreasing access.

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

More pediatric deaths have happened in 2025 than any other year since 2009, reflecting a drop in childhood vaccination rates.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.

The majority of patients with advanced melanoma who stop treatment with immune checkpoint inhibitor therapies remain relapse-free.

Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.

The use of HMME-PDT is associated with a positive response and is well-tolerated among patients with facial port-wine stains.

Power outages longer than four hours, especially large-scale ones, increased the risk for pediatric carbon monoxide poisoning.

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.

Buprenorphine reduced severe maternal morbidity, preterm births, and NICU admissions in pregnant women with opioid use disorder.

The biosimilar SYSA1902 is similar to reference ustekinumab for both efficacy and safety measures among patients with plaque psoriasis.